Jump to main content
Jump to site search

Issue 47, 2014
Previous Article Next Article

Crystallisation control of paracetamol from ionic liquids

Author affiliations


The crystallisation of Active Pharmaceutical Ingredients (API) from conventional organic solvents can yield undesirable crystal habits with poor physical properties that cause downstream processing problems. It has been proposed that ionic liquids (ILs) may offer an opportunity to perform controlled crystallisations from this media. Using paracetamol and the ionic liquids 1-butyl-3-methylimidazolium hexafluorophosphate [bmim][PF6] and 1-hexyl-3-methylimidazolium hexafluorophosphate [hmim][PF6] fundamental understanding of these systems was established by determining the Meta-stable Zone Width (MSZW) before completing a series of cooling crystallisations investigated across a temperature range between 20 °C and 90 °C. It has been shown that paracetamol can be crystallised from these systems to obtain the stable monoclinic form I and that the particle habit and size can be manipulated by changing the IL used, the solution concentration and the mechanism of crystal growth and in some cases crystal habits not commonly found from aqueous or organic solvents were produced. The results demonstrate that ILs may be a viable approach to manipulate crystal properties and should be explored more widely as a potential media for crystallisation of API.

Graphical abstract: Crystallisation control of paracetamol from ionic liquids

Back to tab navigation

Article information

01 Sep 2014
14 Oct 2014
First published
14 Oct 2014

CrystEngComm, 2014,16, 10797-10803
Article type
Author version available

Crystallisation control of paracetamol from ionic liquids

K. B. Smith, R. H. Bridson and G. A. Leeke, CrystEngComm, 2014, 16, 10797
DOI: 10.1039/C4CE01796J

Social activity

Search articles by author